JPH0379998B2 - - Google Patents
Info
- Publication number
- JPH0379998B2 JPH0379998B2 JP303883A JP303883A JPH0379998B2 JP H0379998 B2 JPH0379998 B2 JP H0379998B2 JP 303883 A JP303883 A JP 303883A JP 303883 A JP303883 A JP 303883A JP H0379998 B2 JPH0379998 B2 JP H0379998B2
- Authority
- JP
- Japan
- Prior art keywords
- bilirubin
- test
- potassium ferricyanide
- reagent
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 claims description 88
- 238000012360 testing method Methods 0.000 claims description 32
- -1 potassium ferricyanide Chemical compound 0.000 claims description 26
- 239000003153 chemical reaction reagent Substances 0.000 claims description 24
- 108010015428 Bilirubin oxidase Proteins 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 19
- 238000004737 colorimetric analysis Methods 0.000 claims description 3
- 244000005700 microbiome Species 0.000 claims description 3
- 230000001590 oxidative effect Effects 0.000 claims 1
- 210000002966 serum Anatomy 0.000 description 21
- 230000003287 optical effect Effects 0.000 description 17
- 102000004190 Enzymes Human genes 0.000 description 15
- 108090000790 Enzymes Proteins 0.000 description 15
- 239000000523 sample Substances 0.000 description 11
- 238000008789 Direct Bilirubin Methods 0.000 description 9
- 239000007853 buffer solution Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 6
- 238000000691 measurement method Methods 0.000 description 5
- 239000008363 phosphate buffer Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000872 buffer Substances 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 4
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 3
- 238000012802 pre-warming Methods 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000223251 Myrothecium Species 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- UNKYOXKQMHLGPW-UHFFFAOYSA-N Urobilin IXalpha Natural products CCC1=C(C)C(=O)NC1CC2=NC(=Cc3[nH]c(CC4NC(=O)C(=C4C)CC)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O UNKYOXKQMHLGPW-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- CXPOFJRHCFPDRI-UHFFFAOYSA-N dodecylbenzene;sulfuric acid Chemical compound OS(O)(=O)=O.CCCCCCCCCCCCC1=CC=CC=C1 CXPOFJRHCFPDRI-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000001853 liver microsome Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- KDCCOOGTVSRCHX-UHFFFAOYSA-N urobilin Chemical compound CCC1=C(C)C(=O)NC1CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(CC3C(=C(CC)C(=O)N3)C)=N2)CCC(O)=O)N1 KDCCOOGTVSRCHX-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP303883A JPS59130198A (ja) | 1983-01-11 | 1983-01-11 | ビリルビン測定試薬および測定法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP303883A JPS59130198A (ja) | 1983-01-11 | 1983-01-11 | ビリルビン測定試薬および測定法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59130198A JPS59130198A (ja) | 1984-07-26 |
| JPH0379998B2 true JPH0379998B2 (xx) | 1991-12-20 |
Family
ID=11546135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP303883A Granted JPS59130198A (ja) | 1983-01-11 | 1983-01-11 | ビリルビン測定試薬および測定法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59130198A (xx) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6039566A (ja) * | 1983-08-12 | 1985-03-01 | Oriental Yeast Co Ltd | ビリルビン含有検体の処理法及びビリルビンの定量法 |
| JPH0771515B2 (ja) * | 1989-12-18 | 1995-08-02 | 日本商事株式会社 | ビリルビンの光学的測定法および測定用試薬 |
| CN101622359B (zh) | 2007-04-27 | 2012-10-31 | 爱科来株式会社 | 胆红素测定方法以及用于胆红素测定的分析用具 |
-
1983
- 1983-01-11 JP JP303883A patent/JPS59130198A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59130198A (ja) | 1984-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Munujos et al. | Assay of succinate dehydrogenase activity by a colorimetric-continuous method using iodonitrotetrazolium chloride as electron acceptor | |
| US6008006A (en) | Determination of glycated proteins | |
| JPH0470000B2 (xx) | ||
| WO1997013872A1 (fr) | Procede pour doser les composes d'amadori | |
| US4571383A (en) | Reagent for measuring direct bilirubin by enzymatic method and method for measurement thereof | |
| KR880000753B1 (ko) | 신규의 빌리루빈 산화효소를 포함하는 시약조성물 및 그의 사용방법 | |
| JPS59205999A (ja) | 還元型補酵素の定量方法 | |
| JPH11155596A (ja) | 糖化タンパク質の測定方法 | |
| JP3217066B2 (ja) | アナライトの嫌気的定量に有用な組成物 | |
| JPH0379998B2 (xx) | ||
| Trivedi et al. | New ultraviolet (340 nm) method for assay of uric acid in serum or plasma. | |
| EP0100217A2 (en) | Process for quantitative determination of substrate treated with oxidase | |
| US5262304A (en) | Method for optical measurement of bilirubin and reagent therefor | |
| US4695539A (en) | Process for quantitative determination of substrate treated with oxidase | |
| JP2880209B2 (ja) | 総ビリルビンの定量法及びそれに用いる試薬 | |
| JPWO2006030866A1 (ja) | 尿酸の定量方法 | |
| JP2003169696A (ja) | 生体成分の測定方法およびそれに用いる試薬組成物 | |
| JP2994831B2 (ja) | コレステロールの定量法および定量用試薬 | |
| JP3227486B2 (ja) | 銅の測定方法 | |
| JPH0244396B2 (ja) | Birirubinteiryoho | |
| JP2761768B2 (ja) | Ｎａｄｈの定量法及びそれを用いた胆汁酸の定量法 | |
| JP4544598B2 (ja) | 液状試薬および保存方法 | |
| JPH0731498A (ja) | １，５−アンヒドログルシトールの定量用キット及び該キットを使用する定量法 | |
| JP2880210B2 (ja) | 酵素法による抱合型ビリルビン比色定量法及び試薬 | |
| US4695540A (en) | Quantitative determination of substrate treated with oxidase |